{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T21:42:14Z","timestamp":1759614134037,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.esmoop.2025.105510","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T18:49:49Z","timestamp":1753469389000},"page":"105510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic testing for BRCA1\/2 variants in Northern African women with ovarian and breast cancers: a multicentre study of an under-represented ancestry"],"prefix":"10.1016","volume":"10","author":[{"given":"K.S.","family":"Shohdy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Elnahas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.M.","family":"Barsoum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Elghazawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lasheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gourley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.A.","family":"Azim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2025.105510_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.21037\/ace.2019.10.02","article-title":"Sociodemographic disparities in access to ovarian cancer treatment","volume":"3","author":"Graham","year":"2019","journal-title":"Ann Cancer Epidemiol"},{"issue":"6559","key":"10.1016\/j.esmoop.2025.105510_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105510_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-020-01301-9","article-title":"Genetic and clinical landscape of breast cancers with germline BRCA1\/2 variants","volume":"3","author":"Inagaki-Kawata","year":"2020","journal-title":"Commun Biol"},{"issue":"23","key":"10.1016\/j.esmoop.2025.105510_bib4","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.esmoop.2025.105510_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1758835920975326","article-title":"BRCA1\/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype\u2013phenotype correlation in a cohort of 531 patients","volume":"12","author":"Incorvaia","year":"2020","journal-title":"Ther Adv Med Oncol"},{"issue":"1-2","key":"10.1016\/j.esmoop.2025.105510_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10528-013-9623-8","article-title":"Detection of new point mutations of BRCA1 and BRCA2 in breast cancer patients","volume":"52","author":"Bensam","year":"2014","journal-title":"Biochem Genet"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105510_bib7","first-page":"107","article-title":"Analysis of BRCA1 and BRCA2 mutations in eastern Egyptian breast cancer patients","volume":"31","author":"Hussien","year":"2011","journal-title":"Bull Egypt Soc Physiol Sci"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105510_bib8","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.7314\/APJCP.2016.17.3.1285","article-title":"BRCA1 gene mutations and influence of chemotherapy on autophagy and apoptotic mechanisms in Egyptian breast cancer patients","volume":"17","author":"Abdel-Mohsen","year":"2016","journal-title":"Asian Pacific J Cancer Prev"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105510_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s40487-023-00240-9","article-title":"The landscape of BRCA mutations among Egyptian women with breast cancer","volume":"11","author":"Azim","year":"2023","journal-title":"Oncol Ther"},{"issue":"5","key":"10.1016\/j.esmoop.2025.105510_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"7766","key":"10.1016\/j.esmoop.2025.105510_bib11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-019-1382-1","article-title":"Tumour lineage shapes BRCA-mediated phenotypes","volume":"571","author":"Jonsson","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105510_bib12","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.gim.2022.05.002","article-title":"Reclassification of clinically-detected sequence variants: framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK)","volume":"24","author":"Loong","year":"2022","journal-title":"Genet Med"},{"issue":"12","key":"10.1016\/j.esmoop.2025.105510_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/jmedgenet-2019-106759","article-title":"Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network","volume":"57","author":"Garrett","year":"2020","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105510_bib14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41467-020-20847-0","article-title":"MVP predicts the pathogenicity of missense variants by deep learning","volume":"12","author":"Qi","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105510_bib15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105510_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s10038-017-0355-1","article-title":"Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan","volume":"63","author":"Arai","year":"2018","journal-title":"J Hum Genet"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105510_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-019-05379-6","article-title":"The yield of full BRCA1\/2 genotyping in Israeli Arab high-risk breast\/ovarian cancer patients","volume":"178","author":"Bernstein-Molho","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105510_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74250-2","article-title":"BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan","volume":"10","author":"Abu-Helalah","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105510_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13058-020-01341-3","article-title":"Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia","volume":"22","author":"Tuazon","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105510_bib20","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1158\/0008-5472.CAN-16-0186","article-title":"The BRCA1-\u039411q alternative splice isoform bypasses germline mutations and promotes therapeutic resistance to PARP inhibition and cisplatin","volume":"76","author":"Wang","year":"2016","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105510_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105510_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1158\/1078-0432.CCR-14-2497","article-title":"Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer","volume":"21","author":"Candido-dos-Reis","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105510_bib23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41588-024-01739-1","article-title":"The Egypt Genome Project","volume":"56","author":"Elmonem","year":"2024","journal-title":"Nat Genet"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925013791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925013791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T21:14:08Z","timestamp":1759612448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702925013791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2059702925013791"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105510","relation":{},"ISSN":["2059-7029"],"issn-type":[{"type":"print","value":"2059-7029"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic testing for BRCA1\/2 variants in Northern African women with ovarian and breast cancers: a multicentre study of an under-represented ancestry","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"105510"}}